Bevacizumab (Avastin) vs. Vitrectomy in treatment of macular edema
Not Applicable
- Conditions
- Diabetic retinopathy.Diabetic retinopathy
- Registration Number
- IRCT201207309670N4
- Lead Sponsor
- Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
to have diabetic retinopathy; to have central macular thickness more than 300 µm; to have visual acuity between 20/40 and 20/250 and without a high degree refractive error. Exclusion criteria: patients with HbA1C=10 and/or DBP=100 and hyperlipidemia; patients with one eye; patients with any kind of prior intraoccular surgery; patients with prior administration of Avastin; Glaucoma patients and patients with ischemic maculopathy.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method